WebPDF Version. CAMBRIDGE, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. $168.0 million. The shares are expected to begin trading on the Nasdaq Global Select Market on October 8, 2024 under the ticker symbol “PYXS.” The offering is expected to close on October 13, 2024, subject to the satisfaction of customary closing conditions. WebOct 8, 2024 · The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Pyxis, are expected to be …
Pyxis Tankers Announces Filing of Form 20-F for the Year Ended …
WebPyxis Tankers stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Quote Overview page gives you a snapshot view for a specific symbol. Real-time prices are provided by Cboe BZX Exchange on individual U.S. equities quote pages. During market hours, the real-time Cboe BZX ... WebBD Pyxis™ MedStation™ ES An automated medication dispensing system supporting centralized medication management. It helps clinicians safely and efficiently dispense the right medications, for the right patients at the right time. focused frown facial expresdion
www.sec.gov
Web1 day ago · Pyxis Tankers Inc. operates as a maritime transportation company with a focus on the tanker sector in the United States. Its fleet transports refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, and fuel oil, as well as other liquid bulk items, including vegetable oils and organic chemicals. WebPXS - Pyxis Tankers Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Monthly Draw Settings PXS - Stock Price Chart open in yahoo WebPyxis Oncology, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody, which is in Phase 1 clinical trial for the treatment of solid tumors, including non … focused fund means